Chemotherapy Has No Role in Primary Treatment of Verrucous Carcinoma of Buccal Mucosa
Chemotherapy is not indicated for primary treatment of oral verrucous carcinoma (OVC) of the buccal mucosa—surgery with wide local excision and negative margins remains the definitive standard of care. This distinct low-grade variant of squamous cell carcinoma behaves fundamentally differently from conventional oral squamous cell carcinoma, and applying standard SCCHN treatment algorithms leads to overtreatment 1.
Why Chemotherapy is Not Standard
Verrucous carcinoma is a non-metastasizing malignancy with unique biological behavior:
- Zero metastatic potential: Pooled data from 712 patients showed 0% distant metastases and 0% cervical lymph node metastases in pure OVC 1
- Locally aggressive but indolent: Despite infiltrative growth, it lacks the systemic spread that justifies chemotherapy
- Excellent prognosis with surgery alone: Disease-free survival rates of 82% at 5 years and 66% at 10 years with surgical approaches 2
The EHNS-ESMO-ESTRO guidelines 3 address conventional squamous cell carcinoma of the oral cavity, where chemotherapy plays a role in:
- Postoperative high-risk disease (R1 resection, extracapsular spread)
- Recurrent/metastatic disease not amenable to surgery
These scenarios do not apply to pure verrucous carcinoma, which does not metastasize and has different biological behavior.
Treatment Algorithm for OVC of Buccal Mucosa
Primary Treatment: Surgery
- T1-T2 lesions: Wide local excision with ≥0.5 cm margins, can be performed under local anesthesia 4
- T3-T4 lesions: Wide excision with safe margins, may require partial maxillectomy or marginal mandibulectomy 5
- Neck dissection: NOT indicated even with enlarged lymph nodes—these are reactive, not metastatic 4
Critical Diagnostic Caveat
23.3% of cases have incorrect initial histopathologic diagnosis 4. The key distinction:
- Pure verrucous carcinoma: No metastatic potential, surgery alone sufficient
- Hybrid verrucous carcinoma (with foci of conventional SCC): Behaves like conventional SCC, requires standard SCCHN treatment including potential neck dissection
Close communication between clinician and pathologist is mandatory 6. If hybrid VC is found on final pathology, treat as conventional squamous cell carcinoma per EHNS-ESMO-ESTRO guidelines 3.
Limited Role for Chemotherapy
Chemotherapy has only been explored in exceptional circumstances:
Neoadjuvant/Downstaging Use
- Intraarterial methotrexate infusion achieved complete remission in 15 patients with continuous infusion (50 mg/day for 7.5 days) followed by weekly bolus 7
- Radiotherapy combined with chemotherapy may be considered when surgery is not feasible 2, 8
- However, these are not standard approaches and surgery remains superior
Major Concern: Anaplastic Transformation
Radiotherapy carries risk of malignant transformation to more aggressive squamous cell carcinoma 2. This is a critical reason to avoid radiation when possible and explains why chemotherapy (often combined with radiation in SCCHN protocols) is not routinely used.
Common Pitfalls to Avoid
Treating OVC like conventional oral SCC: This leads to unnecessary neck dissections and adjuvant therapy that only adds morbidity without benefit 4
Inadequate initial biopsy: Superficial biopsies may miss the diagnosis—deep biopsies showing the characteristic "test-tube" growth pattern are essential 5
Missing hybrid verrucous carcinoma: If any foci of conventional SCC are present, the tumor behaves aggressively and requires standard SCCHN treatment protocols 4
Using radiotherapy as primary treatment: Associated with risk of anaplastic transformation and inferior outcomes compared to surgery 2
Bottom Line
For pure verrucous carcinoma of buccal mucosa: surgical excision with negative margins is curative, chemotherapy is not indicated, and neck dissection adds only unnecessary morbidity 4, 1, 6. Reserve systemic therapy protocols for hybrid lesions with conventional SCC components, treating those according to standard SCCHN guidelines 3.